Neuroimaging

PD Dr. med. Martin Klietz

Employees:

  • Dr. med. Stephan Greten
  • Doctor Sophia Marie Rogozinski

 

Cooperation partner on site:

  • Department of Neuroradiology of the MHH (Director: Prof. Dr. H. Lanfermann; Ltd. OA: Prof. Dr. Dr. M. P. Wattjes)
  • Clinical Department of Nuclear Medicine of the MHH (Director: Prof. Dr. F. Bengel; Cerebral Imaging: OA Prof. Dr. Berding)

 

Imaging procedures have become an integral part of modern research into Parkinson's syndromes. They are used to exclude symptomatic lesions and to detect specific degeneration patterns. Using specific imaging techniques, the diagnosis of an atypical Parkinson's syndrome can be confirmed in addition to clinical diagnostics. In addition, modern imaging techniques provide insights into the functional status of the brain and the underlying neurobiology.

 

Through local, national and international interdisciplinary cooperation, the Neuroimaging department has set itself the following goals:

  1. Optimizing the precise differential diagnosis of Parkinson's disease and atypical Parkinson's syndromes in the early course of the disease
  2. Identification of imaging correlates with motor and neuropsychological deficits in Parkinson's syndromes.
  3. Identification of imaging parameters to measure disease progression in Parkinson's syndromes.
  4. Identification of pathological biochemical processes as therapeutic intervention options.

 

The following methods are used for this purpose:

  1. Magnetic resonance imaging (MPRAGE, SWI, DWI, DTI, rs-fMRI, ASL).
  2. Magnetic resonance spectroscopy (see illustration)
  3. SPECT (FP-CIT, IBZM, MIBG)
  4. PET (FDG, microglia marker, tau marker)

 

 

Contact:

Dr. med. Martin Klietz

Clinical Department of Neurology

Hannover Medical School

Carl-Neuberg-Str. 1

30625 Hanover

Phone: 0511 - 532 3122

Mobile: 0176/1532-4944

Email: Klietz.Martin@mh-hannover.de